Xiawei Wei Selected Research

Xiawei Wei Research Topics

Disease

78	Neoplasms (Cancer) 05/2024 - 07/2010
13	Inflammation (Inflammations) 01/2024 - 02/2015
11	COVID-19 07/2024 - 10/2020
10	Bites and Stings (Sting) 02/2024 - 01/2016
9	Carcinogenesis 05/2024 - 01/2020
9	Neoplasm Metastasis (Metastasis) 10/2023 - 02/2014
7	Infections 04/2023 - 01/2021
7	Necrosis 01/2022 - 02/2015
6	Ovarian Neoplasms (Ovarian Cancer) 05/2024 - 01/2019
4	Communicable Diseases (Infectious Diseases) 03/2023 - 12/2019
4	Lung Injury 01/2023 - 05/2019
4	Wounds and Injuries (Trauma) 07/2021 - 01/2013
3	Lung Neoplasms (Lung Cancer) 10/2023 - 01/2020
3	Mitochondrial Diseases (Mitochondrial Disease) 01/2023 - 01/2017
3	Severe Acute Respiratory Syndrome 12/2022 - 09/2021
3	Fibrosis (Cirrhosis) 04/2022 - 08/2014
3	Pneumonia (Pneumonitis) 01/2021 - 01/2017
3	Carcinoma (Carcinomatosis) 06/2020 - 01/2013
2	Lymphoma (Lymphomas) 12/2023 - 01/2019
2	Alzheimer Disease (Alzheimer's Disease) 08/2023 - 01/2020
2	Nasopharyngeal Carcinoma 04/2023 - 01/2021
2	Ascites 12/2021 - 12/2016
2	Ovarian Epithelial Carcinoma 12/2021 - 01/2020
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 12/2021 - 01/2019
2	Virus Diseases (Viral Diseases) 09/2021 - 01/2021
2	Pulmonary Fibrosis (Fibrosing Alveolitis) 06/2021 - 01/2017
2	Breast Neoplasms (Breast Cancer) 02/2021 - 02/2014
2	Cystic Fibrosis (Mucoviscidosis) 01/2021 - 01/2017
2	Hyperthermia 12/2020 - 09/2014
2	Pathologic Processes 12/2020 - 01/2020
1	Acromegaly 01/2023
1	Breakthrough Infections 01/2023
1	Basal Cell Carcinoma (Rodent Ulcer) 01/2023
1	Esophageal Squamous Cell Carcinoma 01/2023

Drug/Important Bio-Agent (IBA)

15	Proteins (Proteins, Gene)FDA Link 05/2024 - 09/2014
12	VaccinesIBA 04/2023 - 01/2018
10	Mitochondrial DNA (mtDNA)IBA 08/2023 - 02/2015
7	CytokinesIBA 01/2024 - 01/2018
6	EnzymesIBA 05/2024 - 01/2017
5	Paclitaxel (Taxol)FDA LinkGeneric 05/2024 - 04/2015
5	Immune Checkpoint InhibitorsIBA 01/2022 - 01/2017
4	Phosphotransferases (Kinase)IBA 04/2023 - 12/2018
4	AntibodiesIBA 01/2023 - 01/2020
4	LigandsIBA 01/2023 - 01/2019
4	Liposomes (Liposome)IBA 12/2022 - 01/2017
4	Cancer VaccinesIBA 01/2022 - 09/2015
4	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 04/2021 - 12/2016
4	MicellesIBA 02/2021 - 01/2013
4	AntigensIBA 01/2021 - 01/2018
3	Cisplatin (Platino)FDA LinkGeneric 04/2023 - 01/2021
3	Therapeutic UsesIBA 01/2023 - 09/2014
3	SodiumIBA 09/2022 - 01/2021
3	RNA (Ribonucleic Acid)IBA 01/2022 - 10/2017
3	Histones (Histone)IBA 01/2022 - 01/2019
3	Nucleic AcidsIBA 01/2022 - 12/2018
3	Adenosine Triphosphatases (ATPase)IBA 01/2022 - 02/2015
2	COVID-19 VaccinesIBA 07/2024 - 01/2023
2	Interferon Type IIBA 02/2024 - 01/2020
2	Vaccine AdjuvantsIBA 02/2024 - 01/2023
2	Agammaglobulinaemia Tyrosine KinaseIBA 12/2023 - 10/2022
2	Monoclonal AntibodiesIBA 04/2023 - 01/2017
2	Neutralizing AntibodiesIBA 04/2023 - 01/2023
2	mRNA VaccinesIBA 03/2023 - 01/2021
2	InflammasomesIBA 01/2023 - 01/2021
2	LipidsIBA 06/2022 - 09/2015
2	Cathepsin BIBA 01/2022 - 01/2020
2	Peptides (Polypeptides)IBA 01/2022 - 01/2019
2	Biomarkers (Surrogate Marker)IBA 01/2022 - 06/2020
2	Angiotensin-Converting Enzyme 2IBA 12/2021 - 01/2021
2	DNA (Deoxyribonucleic Acid)IBA 12/2021 - 05/2019
2	Bleomycin (Blenoxane)FDA LinkGeneric 06/2021 - 01/2017
2	SB 225002IBA 01/2021 - 01/2021
2	napabucasinIBA 10/2020 - 01/2020
2	Doxorubicin (Adriamycin)FDA LinkGeneric 10/2020 - 07/2010
2	Toll-Like Receptor 9IBA 10/2020 - 05/2019
2	tyrosine receptor (receptor, tyrosine)IBA 06/2020 - 12/2018
2	PlatinumIBA 01/2020 - 01/2019
2	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2020 - 11/2019
2	ProdrugsIBA 10/2019 - 01/2019
2	Immune Checkpoint ProteinsIBA 06/2019 - 01/2019
2	Small Interfering RNA (siRNA)IBA 02/2019 - 11/2015
2	Matrix Metalloproteinases (MMPs)IBA 01/2019 - 01/2019
2	CurcuminIBA 04/2015 - 01/2013
1	pexidartinibIBA 05/2024
1	Macrophage Colony-Stimulating FactorIBA 05/2024
1	Inflammation MediatorsIBA 01/2024
1	oxidized- L- alpha- 1- palmitoyl- 2- arachidonoyl- sn- glycero- 3- phosphorylcholineIBA 10/2023
1	HM781-36BIBA 04/2023
1	Serine (L-Serine)FDA Link 01/2023
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2023
1	Interleukin-1 (Interleukin 1)IBA 01/2023
1	Arginine (L-Arginine)FDA Link 01/2023
1	somatostatin receptor 2IBA 01/2023
1	Antineoplastic Agents (Antineoplastics)IBA 01/2023
1	Octreotide (Sandostatin)FDA LinkGeneric 01/2023

Therapy/Procedure

43	Therapeutics 05/2024 - 07/2010
14	Drug Therapy (Chemotherapy) 05/2024 - 01/2019
9	Immunotherapy 03/2023 - 01/2018
4	Radiotherapy 01/2023 - 01/2019
3	Photothermal Therapy 02/2021 - 01/2018